Published in Science on January 13, 1984
Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci U S A (1988) 3.67
A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1. Mol Cell Biol (1987) 2.52
Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol Cell Biol (1993) 2.51
Activation of IFN-beta element by IRF-1 requires a posttranslational event in addition to IRF-1 synthesis. Nucleic Acids Res (1991) 2.33
Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol (1992) 2.19
Isolation and characterization of resident stromal macrophages and hematopoietic cell clusters from mouse bone marrow. J Exp Med (1985) 1.83
Contrasting effect of alpha/beta- and gamma-interferons on expression of macrophage Ia antigens. J Exp Med (1986) 1.55
Impairment of T and B cell development by treatment with a type I interferon. J Exp Med (1998) 1.54
Interferon-inducible gene maps to a chromosomal band associated with a (4;11) translocation in acute leukemia cells. Proc Natl Acad Sci U S A (1987) 1.33
Endogenous interferon production by endotoxin-responsive macrophages provides an autostimulatory differentiation signal. Infect Immun (1984) 1.27
Major differences in the responses of primary human leukocyte subsets to IFN-beta. J Immunol (2010) 1.26
Specific depletion of the B-cell population induced by aberrant expression of human interferon regulatory factor 1 gene in transgenic mice. Proc Natl Acad Sci U S A (1991) 1.20
Critical roles for IFN-beta in lymphoid development, myelopoiesis, and tumor development: links to tumor necrosis factor alpha. Proc Natl Acad Sci U S A (2003) 1.14
Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice. J Clin Invest (1987) 1.14
Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation. Proc Natl Acad Sci U S A (1992) 0.93
Normal human epidermis contains an interferon-like protein. J Cell Biol (1986) 0.92
Interferon gamma and granulocyte/macrophage colony-stimulating factor inhibit growth and induce antigens characteristic of myeloid differentiation in small-cell lung cancer cell lines. Proc Natl Acad Sci U S A (1986) 0.85
Constitutive and trophoblast-specific expression of a class of bovine interferon genes. Proc Natl Acad Sci U S A (1991) 0.84
Interleukin-3 protects mice from acute herpes simplex virus infection. Immunology (1990) 0.84
Inhibition by interleukin-4 of constitutive beta interferon synthesis in mouse macrophages. J Virol (1994) 0.81
Endogenous interferon specifically regulates Newcastle disease virus-induced cytokine gene expression in mouse macrophages. J Virol (1991) 0.81
Activation of 2',5'-oligoadenylate synthetase activity on induction of HL-60 leukemia cell differentiation. Mol Cell Biol (1989) 0.77
Ultrastructure of bone marrow in patients with visceral leishmaniasis. J Clin Pathol (1987) 0.76
Human recombinant macrophage colony-stimulating factor (M-CSF) increases Cl-esterase inhibitor (Cl-INH) synthesis by human monocytes. Immunology (1991) 0.75
Type I interferons inhibit the generation of tumor-associated macrophages. Cancer Immunol Immunother (2009) 0.75
Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity. J Exp Med (1982) 5.33
Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J Cell Biol (1988) 4.63
A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature (1988) 4.09
Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J Immunol (1995) 3.69
Macrophages as a source of tumoricidal activity (tumor-necrotizing factor). Infect Immun (1980) 3.41
Regulation of murine macrophage Ia-antigen expression by products of activated spleen cells. J Exp Med (1980) 2.19
On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J Immunol (1997) 2.14
The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim. J Infect Dis (1980) 2.11
Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors. J Immunol (1980) 2.04
Defense mechanisms against bovine herpesvirus: relationship of virus-host cell events to susceptibility to antibody-complement cell lysis. Infect Immun (1975) 1.98
An investigation of uterine nitric oxide production in mares susceptible and resistant to persistent breeding-induced endometritis and the effects of immunomodulation. Reprod Domest Anim (2012) 1.98
Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J Immunol (1995) 1.94
Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J Immunol (1992) 1.92
Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes. Infect Immun (1980) 1.85
CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J Immunol (1994) 1.83
Host responses to infectious bovine rhinotracheitis virus. III. Isolation and immunologic activities of bovine T lymphocytes. J Immunol (1974) 1.79
BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. I. In vivo studies. J Immunol (1980) 1.74
Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology. J Virol (1989) 1.72
Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice. J Immunol (1995) 1.72
Disease in the scurfy (sf) mouse is associated with overexpression of cytokine genes. Eur J Immunol (1996) 1.71
Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells. Infect Immun (1980) 1.71
Host defense mechanisms against infectious bovine rhinotracheitis virus: in vitro stimulation of sensitized lymphocytes by virus antigen. Infect Immun (1974) 1.69
Biologic properties of chromatographically separated murine thymoma-derived Interleukin 2 and colony-stimulating factor. J Immunol (1981) 1.65
Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J Virol (2001) 1.64
The role of T cell immunity in control of herpes simplex virus. Curr Top Microbiol Immunol (1992) 1.63
Transplantation of T cell-mediated, lymphoreticular disease from the scurfy (sf) mouse. Am J Pathol (1994) 1.59
Antibody-dependent cell-mediated cytotoxicity in cows: comparison of effector cell activity against heterologous erthrocyte and herpesvirus-infected bovine target cells. Infect Immun (1976) 1.59
Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis. Invest Ophthalmol Vis Sci (1984) 1.58
Immunosuppression in viral infections. Rev Infect Dis (1987) 1.55
Mandibular condyle position: comparison of articulator mountings and magnetic resonance imaging. Am J Orthod Dentofacial Orthop (1993) 1.54
A new influenza A virus infection in turkeys II. A highly pathogenic variant, a/turkey/ontario 772/66. Can Vet J (1968) 1.54
Biosynthetic thiolase from zoogloea ramigera. I. Preliminary characterization and analysis of proton transfer reaction. J Biol Chem (1987) 1.44
Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes. Infect Immun (1983) 1.43
Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J Virol (1997) 1.42
Interrelationship between serum beta-lysin, lysozyme, and the antibody-complement system in killing Escherichia coli. Infect Immun (1974) 1.41
Immunopathogenesis of herpetic ocular disease. Immunol Res (1997) 1.40
Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize virus nonstructural proteins. J Virol (1988) 1.37
Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells. J Virol (1987) 1.36
Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro. J Exp Med (1992) 1.36
Host defense mechanisms against infectious bovine rhinotracheitis virus. II. Inhibition of viral plaque formation by immune peripheral blood lymphocytes. Cell Immunol (1975) 1.35
Mechanisms of resistant of herpesviruses: comparison of the effectiveness of different cell types in mediating antibody-dependent cell-mediated cytotoxicity. Infect Immun (1977) 1.34
Mechanisms of recovery from Herpesvirus infections -a review. Can J Comp Med (1978) 1.34
Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J Virol (1992) 1.32
Phenotypic and functional studies on ocular T cells during herpetic infections of the eye. J Immunol (1992) 1.32
Equine herpesvirus-1 consensus statement. J Vet Intern Med (2009) 1.31
Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes. Invest Ophthalmol Vis Sci (1992) 1.30
Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses. Infect Immun (1976) 1.29
Role of mucosal immunity in herpes simplex virus infection. J Immunol (1998) 1.29
Role of T-lymphocyte subsets in recovery from herpes simplex virus infection. J Virol (1984) 1.29
The role of antibody dependent cytotoxicity in recovery from herpesvirus infections. Cell Immunol (1976) 1.27
Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse-models. J Virol (1995) 1.27
Vaccination with recombinant vaccinia viruses expressing ICP27 induces protective immunity against herpes simplex virus through CD4+ Th1+ T cells. J Virol (1995) 1.25
Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J Leukoc Biol (1997) 1.25
The direct antiviral cytotoxicity by bovine lymphocytes is not restricted by genetic incompatibility of lymphocytes and target cells. J Immunol (1977) 1.24
Cell-mediated immunity to herpes simplex virus: recognition of type-specific and type-common surface antigens by cytotoxic T cell populations. Infect Immun (1981) 1.24
Control of stromal keratitis by inhibition of neovascularization. Am J Pathol (2001) 1.24
A longitudinal study of anteroposterior growth changes in the palatine rugae. J Dent Res (1987) 1.23
Correction of defective macrophage differentiation in C3H/HeJ mice by an interferon-like molecule. J Immunol (1982) 1.22
A new influenza virus infection in turkeys. I. Isolation and characterization of virus 6213. Can Vet J (1968) 1.22
Enhanced killing of Candida albicans by murine macrophages treated with macrophage colony-stimulating factor: evidence for augmented expression of mannose receptors. J Immunol (1987) 1.22
In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes. J Immunol (1992) 1.22
Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10. J Immunol (1997) 1.21
Comparison of the antiviral effects of 5-methoxymethyl-deoxyuridine with 5-iododeoxyuridine, cytosine arabinoside, and adenine arabinoside. Antimicrob Agents Chemother (1975) 1.21
Herpetic stromal keratitis in the reconstituted scid mouse model. J Virol (1993) 1.21
Changes in leukocyte populations in pulmonary lavage fluids of calves after inhalation of Pasteurella haemolytica. Am J Vet Res (1985) 1.20
Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses. J Exp Med (1982) 1.20
Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies. J Infect Dis (1991) 1.18
The role of neutrophils in antiviral defense--in vitro studies on the mechanism of antiviral inhibition. J Immunol (1977) 1.18
Antibody dependent cytotoxicity mediated by neutrophils: a possible mechanism of antiviral defense. J Reticuloendothel Soc (1976) 1.17
Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J Virol (1996) 1.17
Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. Int Immunol (1995) 1.16
Role of interferon-gamma in immunity to herpes simplex virus. J Leukoc Biol (1996) 1.16
Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition. J Immunol (1998) 1.16
Immunopathology of herpes simplex virus infections. Curr Top Microbiol Immunol (1992) 1.16
Frictional properties of metal and ceramic brackets. J Clin Orthod (1992) 1.15
The mammary gland of the ox: a convenient source for the repeated collection of neutrophils and macrophages. J Reticuloendothel Soc (1976) 1.15
Augmentation of immunity to herpes simplex virus by in vivo administration of interleukin 2. J Immunol (1985) 1.14
Neutrophils in antiviral immunity: inhibition of virus replication by a mediator produced by bovine neutrophils. J Infect Dis (1980) 1.14
Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules. J Immunol (2001) 1.14
Mediation of an endotoxic effect by macrophages. J Reticuloendothel Soc (1976) 1.13
Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice. Infect Immun (1995) 1.13
Prostaglandin E (PGE) and interleukin-1 beta (IL-1 beta) levels in gingival crevicular fluid during human orthodontic tooth movement. Am J Orthod Dentofacial Orthop (1994) 1.13
Bystander activation involving T lymphocytes in herpetic stromal keratitis. J Immunol (2001) 1.13
The mouse model and understanding immunity to herpes simplex virus. Rev Infect Dis (1992) 1.12
Proportion of T and B lymphocytes in lesions of Marek's disease: theoretical implications for pathogenesis. J Immunol (1973) 1.10
Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0. J Gen Virol (1990) 1.10
Defense mechanisms against infectious bovine rhinotracheitis virus: inhibition of virus infection by murine macrophages. Infect Immun (1975) 1.10
Antileukotoxin antibody produced in the bovine lung after aerosol exposure to viable Pasteurella haemolytica. Am J Vet Res (1985) 1.10
Foals are interferon gamma-deficient at birth. Vet Immunol Immunopathol (2006) 1.09
DNA vaccines -- a modern gimmick or a boon to vaccinology? Crit Rev Immunol (1997) 1.09
Application of the intracellular gamma interferon assay to recalculate the potency of CD8(+) T-cell responses to herpes simplex virus. J Virol (2000) 1.08
HSV-1-mediated modulation of cytokine gene expression in a permissive cell line: selective upregulation of IL-6 gene expression. Virology (1996) 1.08
Bystander activation of CD4(+) T cells can represent an exclusive means of immunopathology in a virus infection. Eur J Immunol (1999) 1.08